Disparities in late-stage cancer diagnosis across a multi-site academic health system

Abstract Background Disparities in cancer stage at diagnosis persist despite the availability of screening for several common cancers. We evaluated demographic, clinical, insurance, and neighborhood-level factors associated with late-stage diagnosis in a multisite academic health system. Methods We conducted a retrospective cohort study of 26,698 adults diagnosed with breast, colorectal, or lung and bronchus cancer from 2015 to 2025 across six University of California academic medical centers. Late-stage disease was defined using structured TNM data corresponding to AJCC stage III or IV. Multivariable logistic regression assessed associations of patient characteristics, insurance coverage, comorbidity burden, and neighborhood context, measured using the Area Deprivation Index (ADI), Social Vulnerability Index (SVI), and Healthy Places Index (HPI), with late-stage diagnosis. We also tested for heterogeneity in the ADI association by cancer type. Results Late-stage disease was identified in 4,701 patients (17.6%). Compared with breast cancer, odds of late-stage diagnosis were higher for colorectal cancer (OR, 8.40; 95% CI, 7.62 to 9.27) and lung and bronchus cancer (OR, 14.24; 95% CI, 12.84 to 15.78). Relative to the least deprived ADI tertile, patients in moderately and highly deprived neighborhoods had higher adjusted odds of late-stage diagnosis (OR, 1.10; 95% CI, 1.01 to 1.20, and OR, 1.21; 95% CI, 1.10 to 1.33, respectively). Medicaid coverage and other or unknown insurance coverage were also associated with higher odds of late-stage disease. SVI was not associated with stage, and HPI did not reach statistical significance. The ADI association varied by cancer type ( P = .0001) and was observed only for breast cancer, for which high neighborhood deprivation was associated with 55% higher odds of late-stage disease (OR, 1.55; 95% CI, 1.31 to 1.85). Conclusion Late-stage cancer diagnosis was strongly associated with cancer type and was also associated with insurance coverage and neighborhood deprivation. The association between neighborhood deprivation and stage was confined to breast cancer, emphasizing the value of cancer-specific approaches to reducing disparities in late-stage diagnosis. Impact Health systems may use neighborhood measures and insurance information to identify populations who could benefit from targeted screening outreach, navigation, and interventions that reduce structural barriers to early cancer detection.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-10-15
DOI
https://doi.org/10.1186/s12885-026-17117-5
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disparities in late-stage cancer diagnosis across a multi-site academic health system

Humberto Parada, Brenton Rose, Noé C. Crespo, Joshua Demb et al.
BMC Cancer
Global Cancer Incidence and Screening
article

Disparities in late-stage cancer diagnosis across a multi-site academic health system

Humberto Parada, Brenton Rose, Noé C. Crespo, Joshua Demb, James Don Murphy, Winta Tsegay Mehtsun, Melody Karen Schiaffino, Matthew P. Banegas, Elena Martínez, Suraj Manohar Rajan, Vivian Hoang Tran, Carol Y. Ochoa Dominguez, Corinne McDaniels
article en

Abstract

Abstract Background Disparities in cancer stage at diagnosis persist despite the availability of screening for several common cancers. We evaluated demographic, clinical, insurance, and neighborhood-level factors associated with late-stage diagnosis in a multisite academic health system. Methods We conducted a retrospective cohort study of 26,698 adults diagnosed with breast, colorectal, or lung and bronchus cancer from 2015 to 2025 across six University of California academic medical centers. Late-stage disease was defined using structured TNM data corresponding to AJCC stage III or IV. Multivariable logistic regression assessed associations of patient characteristics, insurance coverage, comorbidity burden, and neighborhood context, measured using the Area Deprivation Index (ADI), Social Vulnerability Index (SVI), and Healthy Places Index (HPI), with late-stage diagnosis. We also tested for heterogeneity in the ADI association by cancer type. Results Late-stage disease was identified in 4,701 patients (17.6%). Compared with breast cancer, odds of late-stage diagnosis were higher for colorectal cancer (OR, 8.40; 95% CI, 7.62 to 9.27) and lung and bronchus cancer (OR, 14.24; 95% CI, 12.84 to 15.78). Relative to the least deprived ADI tertile, patients in moderately and highly deprived neighborhoods had higher adjusted odds of late-stage diagnosis (OR, 1.10; 95% CI, 1.01 to 1.20, and OR, 1.21; 95% CI, 1.10 to 1.33, respectively). Medicaid coverage and other or unknown insurance coverage were also associated with higher odds of late-stage disease. SVI was not associated with stage, and HPI did not reach statistical significance. The ADI association varied by cancer type ( P = .0001) and was observed only for breast cancer, for which high neighborhood deprivation was associated with 55% higher odds of late-stage disease (OR, 1.55; 95% CI, 1.31 to 1.85). Conclusion Late-stage cancer diagnosis was strongly associated with cancer type and was also associated with insurance coverage and neighborhood deprivation. The association between neighborhood deprivation and stage was confined to breast cancer, emphasizing the value of cancer-specific approaches to reducing disparities in late-stage diagnosis. Impact Health systems may use neighborhood measures and insurance information to identify populations who could benefit from targeted screening outreach, navigation, and interventions that reduce structural barriers to early cancer detection.

BMC Cancer
San Diego State University (US), UC San Diego Health System (US), University of California San Diego (US), Center for Health and Gender Equity (US)
Good health and well-being, Reduced inequalities
Openalex Percentile: Top 17%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.